Loading
Yanuki
ARTICLE DETAIL
Axon (AXON) Stock: Analyst Ratings and Investment Considerations | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Axon (AXON) Stock: Analyst Ratings and Investment Considerations | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026

Finance / Stocks

Axon (AXON) Stock: Analyst Ratings and Investment Considerations

This article examines Wall Street analyst ratings for Axon Enterprise (AXON) to help investors make informed decisions. It explores the reliability of brokerage recommendations and alternative tools like the Zacks Rank.

Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It?
Share
X LinkedIn

axon stock
Axon (AXON) Stock: Analyst Ratings and Investment Considerations Image via Yahoo Finance

Key Insights

  • Axon (AXON) has an average brokerage recommendation (ABR) of 1.38, approximating a Strong Buy to Buy rating.
  • 14 out of 20 analysts recommend a Strong Buy, and 4 recommend a Buy.
  • Brokerage recommendations may be biased due to vested interests.
  • The Zacks Rank is an alternative tool driven by earnings estimate revisions.
  • Axon currently has a Zacks Rank #3 (Hold).

In-Depth Analysis

Wall Street analysts' recommendations can influence stock prices, but their reliability is questionable due to potential biases. Research indicates that brokerage firms tend to issue more 'Strong Buy' recommendations than 'Strong Sell' recommendations. For Axon, 70% of analysts give it a 'Strong Buy'.

The Zacks Rank is presented as an alternative, driven by earnings estimate revisions, which correlate strongly with near-term stock price movements. Unlike ABR, the Zacks Rank maintains a balance across its ratings and is updated more frequently.

Regarding Axon's investment potential, the Zacks Consensus Estimate for the current year's earnings has remained unchanged at $6.37. This stability, combined with its Zacks Rank #3 (Hold), suggests that the stock's performance may align with the broader market in the near term.

Read source article

FAQ

What is the average brokerage recommendation (ABR)?

It is an average of recommendations (Buy, Hold, Sell) made by brokerage firms, on a scale of 1 to 5 (Strong Buy to Strong Sell).

What is Zacks Rank?

A proprietary stock rating tool that categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), based on earnings estimate revisions.

Takeaways

  • Analyst ratings should not be the sole basis for investment decisions.
  • Consider potential biases in brokerage recommendations.
  • The Zacks Rank can be a useful tool for evaluating stock potential.
  • Axon (AXON) is currently rated as a Hold by Zacks Investment Research.

Discussion

Do you find analyst ratings helpful in your investment decisions? Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.